D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$439M |
| 2 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$391M |
| 3 |
Chevron
CVX
|
+$368M |
| 4 |
Williams Companies
WMB
|
+$334M |
| 5 |
Schlumberger
SLB
|
+$255M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$469M |
| 2 |
Meta Platforms (Facebook)
META
|
+$376M |
| 3 |
Biogen
BIIB
|
+$308M |
| 4 |
Netflix
NFLX
|
+$307M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| 1 | Energy | 14.62% |
| 2 | Technology | 12.08% |
| 3 | Healthcare | 11.47% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Industrials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SKUL
1426
DELISTED
SKULLCANDY INC
SKUL
| $2.17M | ﹤0.01% |
282,761
-54,173
| -16% | -$416K |
|
|
ERF
1427
DELISTED
Enerplus Corporation
ERF
| $2.17M | ﹤0.01% |
246,686
+114,600
| +87% | +$1.01M |
|
|
STR
1428
DELISTED
QUESTAR CORP
STR
| $2.17M | ﹤0.01% |
103,540
+87,730
| +555% | +$1.83M |
|
|
QLTY
1429
DELISTED
QUALITY DISTR INC FLA
QLTY
| $2.17M | ﹤0.01% |
140,024
+15,164
| +12% | +$234K |
|
|
ILG
1430
DELISTED
ILG, Inc Common Stock
ILG
| $2.16M | ﹤0.01% |
94,385
+10,117
| +12% | +$231K |
|
|
ORC
1431
Orchid Island Capital
ORC
$1.04B
| $2.16M | ﹤0.01% |
38,447
+16,187
| +73% | +$907K |
|
1432
Capitol Federal Financial
CFFN
$839M
| $2.14M | ﹤0.01% |
+178,078
| New | +$2.14M |
|
|
ELOS
1433
DELISTED
Syneron Medical Ltd
ELOS
| $2.14M | ﹤0.01% |
201,546
+41,759
| +26% | +$443K |
|
|
EVDY
1434
DELISTED
Everyday Health, Inc.
EVDY
| $2.14M | ﹤0.01% |
167,271
+120,241
| +256% | +$1.54M |
|
|
NJ
1435
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
| $2.14M | ﹤0.01% |
114,295
-47,427
| -29% | -$886K |
|
1436
U-Haul Holding Co
UHAL
$10.8B
| $2.13M | ﹤0.01% |
65,240
-38,420
| -37% | -$1.26M |
|
1437
Polaris
PII
$3.22B
| $2.13M | ﹤0.01% |
14,390
-15,003
| -51% | -$2.22M |
|
1438
CVR Energy
CVI
$3.13B
| $2.13M | ﹤0.01% |
+56,545
| New | +$2.13M |
|
1439
Moelis & Co
MC
$5.54B
| $2.12M | ﹤0.01% |
73,976
+50,265
| +212% | +$1.44M |
|
1440
Asbury Automotive
ABG
$4.8B
| $2.12M | ﹤0.01% |
23,412
+14,572
| +165% | +$1.32M |
|
|
DEA
1441
Easterly Government Properties
DEA
$1.07B
| $2.12M | ﹤0.01% |
53,274
-5,243
| -9% | -$209K |
|
1442
Portland General Electric
POR
$4.66B
| $2.12M | ﹤0.01% |
63,831
-137,134
| -68% | -$4.55M |
|
1443
B2Gold
BTG
$5.94B
| $2.11M | ﹤0.01% |
1,380,876
-218,769
| -14% | -$335K |
|
1444
Gyre Therapeutics
GYRE
$711M
| $2.11M | ﹤0.01% |
962
+27
| +3% | +$59.3K |
|
1445
United Microelectronic
UMC
$17B
| $2.11M | ﹤0.01% |
1,027,760
-13,736
| -1% | -$28.2K |
|
1446
Donaldson
DCI
$9.42B
| $2.1M | ﹤0.01% |
58,536
+52,063
| +804% | +$1.86M |
|
1447
PNC Financial Services
PNC
$79.5B
| $2.09M | ﹤0.01% |
21,899
-119,414
| -85% | -$11.4M |
|
|
SZMK
1448
DELISTED
SIZMEK INC COM STK (DE)
SZMK
| $2.09M | ﹤0.01% |
294,839
+25,028
| +9% | +$178K |
|
1449
Harley-Davidson
HOG
$3.63B
| $2.09M | ﹤0.01% |
+37,075
| New | +$2.09M |
|
1450
Sangamo Therapeutics
SGMO
$152M
| $2.08M | ﹤0.01% |
187,879
-213,004
| -53% | -$2.36M |
|